Gold Is Being Reintroduced Into the Monetary System
While the media focuses on political scandals, inflation and coming up with ridiculous acronyms "TACO"... Smart money is tracking a far bigger shift: a gold revaluation is quietly underway. Garrett Goggin, CFA, says this could trigger 100X moves in select miners - and he's identified four with the biggest upside.
Shares Stats
| Shares Outstanding | 946,830,000 |
| Shares Float | 848,750,000 |
| Shares Short | 7,320,000 |
| Insider Holdings | 16% |
| Institution Holdings | 83.82% |
About Lilly(Eli) & Co
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals in the United States, Europe, China, Japan, and internationally. The company offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; Jardiance, Mounjaro, and Trulicity for type 2 diabetes; and Zepbound for obesity. It also provides oncology products, including Alimta, Cyramza, Erbitux, Jaypirca, Retevmo, Tyvyt, and Verzenio. In addition, the company offers Olumiant for rheumatoid arthritis, atopic dermatitis, severe alopecia areata, and COVID-19; Taltz for plaque psoriasis, psoriatic arthritis, ankylosing spondylitis, and non-radiographic axial spondylarthritis; Omvoh for ulcerative colitis; Cymbalta for depressive disorder, diabetic peripheral neuropathic pain, generalized anxiety disorder, fibromyalgia, and chronic musculoskeletal pain; Ebglyss for severe atopic dermatitis; and Emgality for migraine prevention and episodic cluster headache. It has collaborations with Incyte Corporation; Boehringer Ingelheim Pharmaceuticals, Inc.; F. Hoffmann-La Roche Ltd and Genentech, Inc.; Biologics, Inc., AbCellera Biologics Inc.; Verge Genomics; collaboration with AdvanCell to advance novel targeted alpha therapies for the treatment of cancer; and Chugai Pharmaceutical Co., Ltd, as well as Strategic Collaboration with Eli Lilly to advance development of its myeloid engager platform for autoimmune disease. Eli Lilly and Company was founded in 1876 and is headquartered in Indianapolis, Indiana.
General
| Name | Lilly(Eli) & Co |
| Ticker | LLY |
| Exchange | NYSE |
| Sector | Healthcare |
| Industry | Drug Manufacturers - General |
| Currency | USD |
| Country | USA |
| Fiscal Year End | December |
| Full Time Employees | 47,000 |
Highlights
| Analyst Target | 909.42 |
| Market Cap | 776,567,700,000 |
| PE Ratio | 54.41 |
| PEG Ratio | 0.79 |
| EBITDA | 24,775,100,416 |
Financials
| Curr Year EPS Estimate | 22.85 |
| Next Quarter EPS Estimate | 6.13 |
| Profit Margin | 25.91% |
| Operating Margin | 42.13 |
| Return on Assets | 0.17 |
| Return on Equity | 0.86 |
| Revenue | 53.3B |
| Earnings Per Share | 17.42 |
| Revenue Per Share | 59.22 |
| Gross Profit | 44,011,499,520 |
| Quarterly Revenue Growth | 0.38 |
Valuation
| Trailing PE | 47.38 |
| Forward PE | 24.04 |
| Price/Sales (Trailing 12 Mt.) | 13.89 |
| Price/Book (Most Recent Quarter) | 35.55 |
Dividend
Lilly(Eli) & Co pays out a dividend of $5.87 per share, with a dividend yield of 0.72%.
LLY's last dividend payment was made to shareholders on September 10, 2025.
They pay out 44.39% of their earnings out as a dividend.
Recent Dividends
| Sep 10, 2025 | $1.50 |
| Jun 10, 2025 | $1.50 |
| Mar 10, 2025 | $1.50 |
| Dec 10, 2024 | $1.30 |
| Sep 10, 2024 | $1.30 |
| Jun 10, 2024 | $1.30 |
| Mar 8, 2024 | $1.30 |
| Dec 8, 2023 | $1.13 |
Nvidia's Value Reaches $4.6 Trillion, Bitcoin Eyes $120,000: What's Moving Markets Thursday?
On the second day of the U.S. government shutdown, Wall Street remains largely subdued, with indexes showing only slight midday declines after touching fresh record highs at the open.
FAA Faces Furlough Of 11,000 Employees, Airlines Warn Of Delays Amid Shutdown Threat
11,000 FAA employees face potential furloughs due to government funding lapse. ATC and TSA workers would work without pay.
New Biotech Offering Targets $426B Rare Disease Market - Ad
The rare disease drug space is growing fast-and so is investor interest. With exclusivity, pricing power and major M&A moves, the rare disease space is getting interesting. This company has the science and the experience.
Palantir Stock Climbs Nearly 2% In Thursday Pre-Market: What's Going On?
Shares of Palantir Technologies Inc. (NASDAQ: PLTR) climbed 1.53% in Thursday pre-market after it signed a strategic deal worth billions with the U.K. government.
IBM Stock Jumps 5% After Quantum Computing Breakthrough
Shares of International Business Machines Corporation (NASDAQ: IBM) are up Thursday after the company announced it reached a technological milestone in quantum computin
[Revealed] Trump's Next AI Executive Orders? - Ad
A White House insider with direct ties to Trump's inner circle just revealed what he calls "Manhattan II" - a potential $2.2 trillion AI initiative set to launch as soon as Oct 15. He says this could mirror past U.S. projects that minted fortunes - with small firms soaring 5,000% to 10,000% over two decades. And now he's giving away his #1 stock pick for free before the deadline.
Bitcoin, Ethereum, Dogecoin Consolidate As XRP Tries To Push Higher
Cryptocurrency markets are trading sideways on Tuesday as investors position ahead of the Federal Reserve's interest rate decision.
Bitcoin Hits $120,000 As JPMorgan Lifts Year-End Target To $165,000
Bitcoin (CRYPTO: BTC) broke above $120,000 in Thursday trading as JPMorgan Chase (NASDAQ:JPM) raised its year-end price
Nvidia Is About to Shock the World: October 23rd - Ad
Jeff Brown, the tech legend who picked shares of Nvidia in 2016 before they jumped by more than 22,000%, is warning everyone to... Mark this date on your calendar: October 23rd! That's when Nvidia could help send shares of this Elon Musk supplier skyrocketing higher.
Ex-Trump Lawyer Draws Parallels Between Kimmel Suspension And Nazi Regime
Ty Cobb has drawn a comparison between the suspension of comedian Jimmy Kimmel and the tactics employed by the Nazis.
What to know about Brendan Carr, the head of the Federal Communications Commission
WASHINGTON (AP) — ABC took comic Jimmy Kimmel's off the air indefinitely Wednesday, just hours after Federal Communications Commission chairman Brendan Carr called his comments about Charlie Kirk's assassination “truly sick.”
The "Mar-A-Lago Accord" Is Now Underway - Ad
The global order is in chaos. And according to 40-year market veteran Dr. David Eifrig, the biggest controlled demolition of the old monetary order in history could now be here, too. That means if you don't take action today, your wealth could decline by 40%... (Yes, even your cash savings.)
Tesla, Warner Bros. Discovery Get Partial Victory In AI Image Lawsuit From 'Blade Runner' Production Company
Tesla may have used images similar to "Blade Runner 2049" during its robotaxi event, according to a lawsuit. Here's an update on the case.
Donald Trump Declares Harsh Media Coverage of Him 'No Longer Free Speech' But 'Illegal'
President Donald Trump has labeled negative media coverage of him as "illegal."
Another Gold High? Here's the Move Wall Street Is Missing ... - Ad
Gold just surged past $3,600, up 45% in a year - but Sean Brodrick says $6,900 could be next. History shows when gold booms, one hidden play has delivered far bigger gains - 21x, 49x, even 1,386x. The same strategy once handed 26,000% profits. And Sean says it's back on the table now.
Cathie Wood Loads Up On Bullish Inc, Pony AI And Robinhood — Dumps Kratos Defense Amid Taiwan Drone Buzz
On Sept 17, 2025, Cathie Wood-led Ark Invest executed significant trades involving Bullish, Kratos Defense, Pony AI, and Robinhood. These reflect Ark's focus on emerging tech and defense sectors.
New York City's Wealthiest Neighborhoods Witness 60% Rent Surge Since Pandemic
House rental rates in some of the wealthiest neighborhoods of New York City have surged by over 60% since the COVID-19 pandemic began, putting even high-income earners in a tight spot.
Biotech With Multiple Orphan Drugs Is Quietly Opening Its Doors - Ad
A promising biotech developing treatments for rare childhood brain diseases is opening a new raise. Its lead drug has fast-track status, orphan designations, is nearing Phase 2 and backed by a Global Integrator.
Big Tech's energy-hungry data centers could be bumped off grids during power emergencies
HARRISBURG, Pa. (AP) — With the explosive growth of Big Tech's data centers threatening to overload U.S. electricity grids, policymakers are taking a hard look at a tough-love solution: bumping the energy-hungry data centers off grids during power emergencies.
Johnson & Johnson's Tecvayli-Darzalex Combo Shows 100% Response In Newly Diagnosed Myeloma Patients
Johnson & Johnson's Tecvayli-Darzalex regimen showed 100% response rates and high MRD negativity in newly diagnosed multiple myeloma patients.
Elon's $25 Trillion Confession - Ad
Elon Musk: "Tesla will become a $25 trillion company." That would make Tesla 8x bigger than Apple today. How is that possible? He admits it's all thanks to this one AI breakthrough that will take AI out of our computer screens and manifest a 250x boom here in the real world.
Trump Warns Of Massive Debt, Peter Grandich Warns Of 'Most Dangerous Time in 40 Years,' Fed Trapped In Inflation And More: This Week In Economy
Peter Grandich warns that we're in the "most dangerous time in 40 years," as gold surges and the Fed faces challenges with inflation and unemployment.
Anthony Scaramucci Says A Tesla–xAI Merger 'Feels Inevitable' As Shareholders Push For Investment In Grok Parent
Anthony Scaramucci said a Tesla–xAI merger "feels inevitable," amplifying shareholder pressure and investor debate as Musk backs closer ties between the EV maker and his $100 billion AI startup.
Rare Disease Biotech Offers Access Ahead of Key Milestone - Ad
This late-stage biotech is gearing up for Phase 2 trials with an FDA-designated orphan drug. It's already drawing comparisons to recent billion-dollar exits. Backed by a proven biotech incubator, it's now offering early access to its raise.
Consumer Tech News (Sep. 15 – Sep. 19): Fed Rate Cut Lifts Wall Street To Records As Meta Unveils Smart Glasses, Nvidia-Intel Forge Chip Pact
Wall Street rallied to record highs after the Fed's rate cut, while Meta launched new smart glasses, Nvidia teamed with Intel on chips, and big names like General Mills, FedEx, and Darden reported earnings.
PepsiCo May See Lower Q3 Gross Margins From Tariff Pressure, 'Stretched' Frito-Lay Pricing
PepsiCo, Inc. (NASDAQ: PEP) shares are trading slightly higher on Friday.
The Tesla Shock Nobody Sees Coming - Ad
While headlines scream "Tesla is doomed"...Jeff Brown has uncovered a revolutionary AI breakthrough buried inside Tesla's labs. One that is helping AI escape from our computer screens and manifest itself here in the real world all while creating a 25,000% growth market explosion starting as early as October 23rd.
US orders Delta and Aeromexico to dissolve their partnership over fairness concerns in Mexico
U.S. Transportation Secretary Sean Duffy is following through on to force Delta and Aeromexico to dissolve their longtime partnership because of his concerns that Mexico isn't being fair to U.S. airlines.
Lam Research And JSR Resolve Legal Disputes As They Team Up On AI Era Chips
Lam Research and JSR Corp agreed to collaborate and cross-license, combining their expertise to accelerate semiconductor manufacturing and reduce costs.
Gold Is Being Reintroduced Into the Monetary System - Ad
While the media focuses on political scandals, inflation and coming up with ridiculous acronyms "TACO"... Smart money is tracking a far bigger shift: a gold revaluation is quietly underway. Garrett Goggin, CFA, says this could trigger 100X moves in select miners - and he's identified four with the biggest upside.
Ethereum Co-Founder Vitalik Buterin Responds to Security Concerns Over OpenAI's ChatGPT
Ethereum co-founder Vitalik Buterin has voiced his concerns over potential security risks associated with OpenAI's ChatGPT, which could lead to the leakage of personal user data.
AquaBounty Technologies Stock Explodes Over 98% After Hours: Here's Why
AquaBounty Technologies saw a massive 98.25% surge in after-hours trading to $2.26, following confirmation that it had met NASDAQ's minimum bid price requirement, resolving its earlier delisting risk.
New Biotech Offering Targets $426B Rare Disease Market - Ad
The rare disease drug space is growing fast-and so is investor interest. With exclusivity, pricing power and major M&A moves, the rare disease space is getting interesting. This company has the science and the experience.
Opendoor Stock Rallies On Expansion And Short Squeeze Hopes
Opendoor stock rallied on Wednesday after it announced an expansion of U.S. operations, but it didn't specify which operations.
A United Airlines passenger plane makes emergency landing in Osaka as cargo fire is suspected
NAGASAKI, Japan (AP) — A United Airlines passenger plane carrying 142 people and bound for the Philippine island of Cebu made an emergency landing in Osaka on Friday after an indicator showed a fire in the cargo room, Japanese aviation officials said.
[Revealed] Trump's Next AI Executive Orders? - Ad
A White House insider with direct ties to Trump's inner circle just revealed what he calls "Manhattan II" - a potential $2.2 trillion AI initiative set to launch as soon as Oct 15. He says this could mirror past U.S. projects that minted fortunes - with small firms soaring 5,000% to 10,000% over two decades. And now he's giving away his #1 stock pick for free before the deadline.
Benzinga Bulls And Bears: Intel, FedEx, Cracker Barrel — And Markets Close At Record Highs
Benzinga examined the prospects for many investors' favorite stocks over the last week — here's a look at some of our top stories.
Apple's iPhone 17 Series Takes Off, Meta's New Smart Glasses And Major Partnerships In AI Space: This Week In AI
This weekend's tech roundup featured Apple's strong iPhone 17 launch in China and India, Meta's new smart glasses, major AI partnerships like Intel-Nvidia and PayPal-Google, and Jim Cramer questioning Huawei's chip breakthrough.
Nvidia Is About to Shock the World: October 23rd - Ad
Jeff Brown, the tech legend who picked shares of Nvidia in 2016 before they jumped by more than 22,000%, is warning everyone to... Mark this date on your calendar: October 23rd! That's when Nvidia could help send shares of this Elon Musk supplier skyrocketing higher.
Small Caps Rally, Intel Rockets On Best Day Ever: What's Moving Markets Thursday?
The Russell 2000, which tracks small caps, rallied on Thursday, outpacing large-cap benchmarks as investors piled into interest-rate-sensitive stocks a day after the Federal Reserve cut rates by 25 basis points and signaled more easing ahead
Information, charts or examples are for illustration and educational purposes only and not for individualized investment management This message contains commercial elements, such as advertising. We only send these offers to those who have opted in to our newsletter. Past performance is not indicative of future results. For these reasons we strongly suggest trading in a DEMO/Simulated account. The information provided by us is for educational and informational purposes only. We make no representations or warranties concerning the products, practices or procedures of any company or entity mentioned or recommended and have not determined if the statements and opinions of the advertiser are accurate, correct or truthful. If you use, act upon or make decisions in reliance on information contained or any external source linked within it, you do so at your own peril and agree to hold us, our officers, directors, shareholders, affiliates and agents without fault.